EP0095944A3 - Anti-androgenic preparation for oral cavity administration - Google Patents

Anti-androgenic preparation for oral cavity administration Download PDF

Info

Publication number
EP0095944A3
EP0095944A3 EP83303181A EP83303181A EP0095944A3 EP 0095944 A3 EP0095944 A3 EP 0095944A3 EP 83303181 A EP83303181 A EP 83303181A EP 83303181 A EP83303181 A EP 83303181A EP 0095944 A3 EP0095944 A3 EP 0095944A3
Authority
EP
European Patent Office
Prior art keywords
carbon
preparation
oral cavity
androgenic
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP83303181A
Other languages
German (de)
French (fr)
Other versions
EP0095944A2 (en
Inventor
Yasuaki Ogawa
Katsumi Iga
Junichi Satou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of EP0095944A2 publication Critical patent/EP0095944A2/en
Publication of EP0095944A3 publication Critical patent/EP0095944A3/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A pharmaceutical composition, suitable for use in treating prostatomegaly, comprises an anti-androgenically active com­ pound represented by the formula [I]:
EP83303181A 1982-06-02 1983-06-02 Anti-androgenic preparation for oral cavity administration Withdrawn EP0095944A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP95070/82 1982-06-02
JP57095070A JPS58210007A (en) 1982-06-02 1982-06-02 Oral preparation for giving to upper buccogingival transition

Publications (2)

Publication Number Publication Date
EP0095944A2 EP0095944A2 (en) 1983-12-07
EP0095944A3 true EP0095944A3 (en) 1985-05-08

Family

ID=14127726

Family Applications (1)

Application Number Title Priority Date Filing Date
EP83303181A Withdrawn EP0095944A3 (en) 1982-06-02 1983-06-02 Anti-androgenic preparation for oral cavity administration

Country Status (7)

Country Link
EP (1) EP0095944A3 (en)
JP (1) JPS58210007A (en)
KR (1) KR840005021A (en)
DK (1) DK249083D0 (en)
ES (1) ES8503247A1 (en)
GR (1) GR78809B (en)
PT (1) PT76785A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4755386A (en) * 1986-01-22 1988-07-05 Schering Corporation Buccal formulation
GB8608818D0 (en) * 1986-04-11 1986-05-14 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
FR2827517B1 (en) 2001-07-23 2003-10-24 Bioalliance Pharma EXTENDED RELEASE BIOADHESIVE THERAPEUTIC SYSTEMS
EP1837020A1 (en) 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856829A (en) * 1970-01-07 1974-12-24 Takeda Chemical Industries Ltd 16{62 -hydrocarbon substituted estrane compounds
GB1516359A (en) * 1974-09-24 1978-07-05 Nippon Kayaku Kk Pharmaceutical preparation for oral cavity administration
EP0044495A1 (en) * 1980-07-21 1982-01-27 Schering Aktiengesellschaft 16-Beta ethyl steroids, compositions containing them and process for their preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856829A (en) * 1970-01-07 1974-12-24 Takeda Chemical Industries Ltd 16{62 -hydrocarbon substituted estrane compounds
GB1516359A (en) * 1974-09-24 1978-07-05 Nippon Kayaku Kk Pharmaceutical preparation for oral cavity administration
EP0044495A1 (en) * 1980-07-21 1982-01-27 Schering Aktiengesellschaft 16-Beta ethyl steroids, compositions containing them and process for their preparation

Also Published As

Publication number Publication date
JPS58210007A (en) 1983-12-07
PT76785A (en) 1983-06-01
EP0095944A2 (en) 1983-12-07
KR840005021A (en) 1984-11-03
DK249083D0 (en) 1983-06-01
GR78809B (en) 1984-10-02
ES522904A0 (en) 1985-02-16
ES8503247A1 (en) 1985-02-16

Similar Documents

Publication Publication Date Title
CA2066403A1 (en) Transmucosal dosage form
IL112518A0 (en) Thyroid hormone fast dispersing pharmaceutical composition
RU94046316A (en) Use of high effective phosphonates for preparing medicinal agents for osteoporosis treatment
JPS5524474B2 (en)
HUT45403A (en) Process for production of medical compositions with increased percutane penetrating ability
IE882091L (en) Pharmaceutical compositions comprising sometostatin¹analogues
ES8307496A1 (en) Galenic preparation.
KR830002510A (en) Composition consisting of biologically active compound and hydroxyalkyl starch
EP0095944A3 (en) Anti-androgenic preparation for oral cavity administration
DE3568440D1 (en) New (8s)-8-fluoroerythromycin derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
US3882241A (en) Use of prostaglandins E and F for prevention of pregnancy in humans
HUT37767A (en) Process for preparing isoxazole derivatives further pharmaceutical compositions containing such compounds as active substances
KR960700701A (en) PHARMACEUTICAL COMPOSITIONS COMPRISING PARACETAMOL AND L-CYSTEINE OR A PRECURSOR THEREOF
EP0209843A3 (en) Benzylpiperazine compound, preparation thereof, pharmaceutical composition, and use
NO872115L (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE STEROIDS.
LLOYD et al. Testosterone Cyclopentylpropionate: a long-acting androgen
KR870011135A (en) Cis-6- (4-acetanilideo) -8,9-dimethoxy-2-methyl-1,2,3,4,4a, 10b-hexedro-benzo [c] [1,6] to naphthyridine Composed pharmaceutical compositions and uses thereof
WO1997049662A1 (en) Quinone bacterial inhibitors
GR3032156T3 (en) Treatment of human lactation failure.
GB1326528A (en) Method of contraception and compositions used therein
KR870007098A (en) Fluorinated diaminoalkyne derivatives and preparation method thereof
US4794119A (en) Aqueous crystalline suspension of steroid glycoesters
ES8401721A1 (en) Non-irritating injectable dosage forms
JPS6440425A (en) Therapeutical composition for cardiac arrhythmia
JPS6434915A (en) Drug preparation for skin

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): BE CH DE FR GB IT LI NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Designated state(s): BE CH DE FR GB IT LI NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19860109

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SATOU, JUNICHI

Inventor name: OGAWA, YASUAKI

Inventor name: IGA, KATSUMI